DEVELOPMENT AND EXCLUSIVE LICENSE AGREEMENTDevelopment and Exclusive License Agreement • September 19th, 2023 • Dyadic International Inc • Biological products, (no disgnostic substances)
This DEVELOPMENT AND EXCLUSIVE LICENSE AGREEMENT (“Agreement”) is made as of September 18, 2023 (the “Effective Date”) by and between Dyadic International (USA), Inc., a corporation having a place of business at 140 Intracoastal Pointe Drive, Suite 404, Jupiter, FL 33477-5094 (“Licensor”), and INZYMES ApS, a corporation having a place of business at Strandvejen 60, 2900 Hellerup, Denmark (“Licensee”). Licensor and Licensee are each referred to herein as such or, individually, as a “Party” or, collectively, as “Parties.”
